Dow Jones

39,512.84

0.32%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NYSE
Aventis New Ads (AVE)
Aventis New Ads (AVE) News

Aventis (AVE)

Aventis New Ads

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AVE

1 2 Next >>

Date	Time	Source	Headline	Symbol	Company
15/10/2004	22:03	PR Newswire (US)	Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A	NYSE:AVE	Aventis New Ads
04/10/2004	20:44	PR Newswire (US)	Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers	NYSE:AVE	Aventis New Ads
22/09/2004	22:23	PR Newswire (US)	Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease	NYSE:AVE	Aventis New Ads
21/09/2004	14:30	PR Newswire (US)	Aventis Named to List of Top 100 Companies for Working Mothers	LSE:AVE
16/09/2004	08:00	PR Newswire (US)	The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity	LSE:AVE
14/09/2004	14:30	PR Newswire (US)	Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease	NYSE:AVE	Aventis New Ads
19/08/2004	14:00	PR Newswire (US)	FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer	NYSE:AVE	Aventis New Ads
11/08/2004	16:39	PR Newswire (US)	Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole	NYSE:AVE	Aventis New Ads
06/08/2004	01:02	PR Newswire (US)	Ventiv Health Announces Sales and Marketing Agreement with Aventis	NYSE:AVE	Aventis New Ads
03/08/2004	19:58	PR Newswire (US)	FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)	NYSE:AVE	Aventis New Ads
28/07/2004	20:31	PR Newswire (US)	Aventis Reports Second-Quarter and First-Half Results for 2004	NYSE:AVE	Aventis New Ads
27/07/2004	16:29	PR Newswire (US)	Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent	LSE:AVE
07/07/2004	14:00	PR Newswire (US)	New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes	LSE:AVE
23/06/2004	15:50	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	LSE:AVE
14/06/2004	16:43	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend	LSE:AVE
07/06/2004	18:00	PR Newswire (US)	Two Landmark Studies Show That Taxotere(R) Significantly Improves Survival in Men With Prostate Cancer	NYSE:AVE	Aventis New Ads
05/06/2004	15:00	PR Newswire (US)	Investigators Report Taxotere(R) Offers Significant Survival Benefits for Head and Neck Cancer Patients	NYSE:AVE	Aventis New Ads
01/06/2004	20:40	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	LSE:AVE
28/05/2004	18:00	PR Newswire (US)	Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program in Melanoma	NYSE:AVE	Aventis New Ads
27/05/2004	08:00	PR Newswire (US)	Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement	LSE:AVE
26/05/2004	16:05	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004	LSE:AVE
26/05/2004	14:00	PR Newswire (US)	Two Landmark Studies of Taxotere(R) in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session	NYSE:AVE	Aventis New Ads
23/05/2004	18:15	PR Newswire (US)	Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients	LSE:AVE
23/05/2004	18:15	PR Newswire (US)	Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against Streptococcus	LSE:AVE
19/05/2004	20:39	PR Newswire (US)	Aventis Receives FDA Approval for Taxotere(R) in Prostate Cancer	NYSE:AVE	Aventis New Ads
18/05/2004	14:01	PR Newswire (US)	Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women with	LSE:AVE
05/05/2004	16:12	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis	LSE:AVE
03/05/2004	20:52	PR Newswire (US)	FDA Advisory Committee Reviews Genasense(TM) for Use in Advanced Melanoma	NYSE:AVE	Aventis New Ads
30/04/2004	20:55	PR Newswire (US)	Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close Contacts	LSE:AVE
29/04/2004	19:03	PR Newswire (US)	Aventis Reports First-Quarter Results for 2004	LSE:AVE